GASTROINTESTINAL PERFORATION side effect
What is GASTROINTESTINAL PERFORATION ?Drugs associated with GASTROINTESTINAL PERFORATION
ALDACTONE AVASTIN AZULFIDINE BEVACIZUMAB BUSULFAN CAPECITABINE ENBREL ESOMEPRAZOLE EXTRANEAL FLUOROURACIL FOSAMAX GEMCITABINE HYDROXYCHLOROQUI INDOCIN ISOVORIN IXABEPILONE KALETRA LEUCOVORIN LORTAB MABTHERA MIRENA MOBIC NEXAVAR PEMETREXED RITUXAN SORAFENIB TAXOL TEMODAL XELODAGASTROINTESTINAL PERFORATION : Fluorouracil Side Effects Report #5647426-6
Physician from JAPAN reported FLUOROURACIL problem on Feb 25, 2008. Female patient was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . FLUOROURACIL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN, CALCIUM LEVOFOLINATE. Patient recovered.
GASTROINTESTINAL PERFORATION : Esomeprazole Side Effects Report #5652956-7
ESOMEPRAZOLE MAGNESIUM problem was reported by a Consumer or non-health professional from on Feb 29, 2008. Female patient, 68 years of age, weighting 116.8 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoarthritis, eczema, lumbar spinal stenosis, hyperlipidaemia, cataract and was treated with ESOMEPRAZOLE MAGNESIUM. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, liver disorder, pyelonephritis, . ESOMEPRAZOLE MAGNESIUM dosage: unknown. During the same period patient was treated with MOBIC, MYSER, OPALMON, LIPITOR, ARTZ DISPO, XYLOCAINE, MUCOSTA, KARY UNI. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5657618-8
Pharmacist from UNITED STATES reported AVASTIN problem on Mar 07, 2008. Female patient, weighting 130.0 lb, was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . AVASTIN dosage: 590MG Q14D IV DRIP. During the same period patient was treated with ONXOL. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Sorafenib Side Effects Report #5662396-2
SORAFENIB problem was reported by a Physician from ITALY on Mar 10, 2008. Male patient, 59 years of age, weighting 149.9 lb, was diagnosed with pancreatic carcinoma and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 01/30/2008.
GASTROINTESTINAL PERFORATION : Taxol Side Effects Report #5664726-4
Physician from JAPAN reported TAXOL problem on Mar 10, 2008. Female patient, 67 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, white blood cell count decreased, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, KYTRIL, NASEA, DEXAMETHASONE PHOSPHATE, DIPHENHYDRAMINE, RANITIDINE, SHAKUYAKU. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Bevacizumab Side Effects Report #5673697-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Bevacizumab Side Effects Report #5620647-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 01, 2008. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5625187-4
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Jan 29, 2008. Male patient was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, neoplasm progression, oedema, . AVASTIN dosage: unknown. During the same period patient was treated with XELODA, OXALIPLATIN. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5639601-1
Physician from UNITED KINGDOM reported AVASTIN problem on May 30, 2007. Male patient was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, sepsis, . AVASTIN dosage: 480 MG, UNK. During the same period patient was treated with XELODA. Patient died on 03/10/2007.
GASTROINTESTINAL PERFORATION : Nexavar Side Effects Report #5645281-1
NEXAVAR problem was reported by a Physician from BELGIUM on Feb 25, 2008. Male patient, 60 years of age, was diagnosed with metastases to peritoneum, metastases to central nervous system and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, . NEXAVAR dosage: unknown. During the same period patient was treated with CORTISONE. Patient was hospitalized. Patient died on 01/31/2008.
GASTROINTESTINAL PERFORATION : Isovorin Side Effects Report #5602097-X
Health Professional from JAPAN reported ISOVORIN problem on Jan 16, 2008. Female patient, 54 years of age, was diagnosed with rectal cancer metastatic and was treated with ISOVORIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, rectal perforation, . ISOVORIN dosage: 100 MG. During the same period patient was treated with FLUOROURACIL, AVASTIN, ELPLAT. Patient recovered.
GASTROINTESTINAL PERFORATION : Capecitabine Side Effects Report #5506438-3
CAPECITABINE problem was reported by a Physician from UNITED STATES on Oct 13, 2007. Female patient, 66 years of age, weighting 174.8 lb, was diagnosed with colon cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . CAPECITABINE dosage: 500 MG, BID. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient died on 08/25/2007.
GASTROINTESTINAL PERFORATION : Extraneal Side Effects Report #5509906-3
Consumer or non-health professional from FRANCE reported EXTRANEAL problem on Oct 30, 2007. Female patient, 36 years of age, was diagnosed with peritoneal dialysis and was treated with EXTRANEAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritonitis, sclerosing encapsulating peritonitis, . EXTRANEAL dosage: unknown. During the same period patient was treated with DIANEAL, NUTRINEAL NOS WITH AMINO ACIDS, FRESENIUS ISO, CELIPROLOL, EUPRESSYL. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Pemetrexed Side Effects Report #5510217-0
PEMETREXED problem was reported by a Physician from JAPAN on Oct 25, 2007. Male patient, weighting 103.6 lb, was diagnosed with pleural mesothelioma, vitamin supplementation, cancer pain and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, stress cardiomyopathy, . PEMETREXED dosage: 740 MG, OTHER. During the same period patient was treated with CISPLATIN, PANVITAN, METHYCOBAL, GOODMIN, POSTERISANTE, OXYCONTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/31/2007.
GASTROINTESTINAL PERFORATION : Extraneal Side Effects Report #5517524-6
Consumer or non-health professional from FRANCE reported EXTRANEAL problem on Nov 02, 2007. Male patient, 80 years of age, was diagnosed with peritoneal dialysis and was treated with EXTRANEAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, peritoneal infection, sclerosing encapsulating peritonitis, . EXTRANEAL dosage: unknown. During the same period patient was treated with DIANEAL PD, ATENOLOL, PHYSIONEAL. Patient died on 06/01/2007.
GASTROINTESTINAL PERFORATION : Aldactone Side Effects Report #5523641-7
ALDACTONE problem was reported by a Physician from JAPAN on Nov 20, 2007. Female patient was diagnosed with rectal cancer metastatic and was treated with ALDACTONE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, haemolytic anaemia, leukopenia, . ALDACTONE dosage: unknown. During the same period patient was treated with LASIX, FAMOTIDINE, NAPROXEN, BEVACIZUMAB, ISOVORIN, IRINOTECAN, FLUOROURACIL, OXALIPLATIN. Patient recovered.
GASTROINTESTINAL PERFORATION : Taxol Side Effects Report #5530270-8
Health Professional from JAPAN reported TAXOL problem on Nov 28, 2007. Male patient, 74 years of age, was diagnosed with lung adenocarcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, septic shock, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient recovered.
GASTROINTESTINAL PERFORATION : Pemetrexed Side Effects Report #5475958-2
PEMETREXED problem was reported by a Physician from JAPAN on Sept 27, 2007. Male patient, weighting 103.6 lb, was diagnosed with pleural mesothelioma, cancer pain and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, stress cardiomyopathy, . PEMETREXED dosage: unknown. During the same period patient was treated with CISPLATIN, GOODMIN, POSTERISANTE, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 08/30/2007.
GASTROINTESTINAL PERFORATION : Mobic Side Effects Report #5484281-1
Physician from AUSTRALIA reported MOBIC problem on Oct 12, 2007. Female patient was treated with MOBIC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . MOBIC dosage: unknown. Patient died.
GASTROINTESTINAL PERFORATION : Leucovorin Side Effects Report #5494827-5
LEUCOVORIN CALCIUM problem was reported by a Health Professional from JAPAN on Oct 23, 2007. Male patient was treated with LEUCOVORIN CALCIUM. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . LEUCOVORIN CALCIUM dosage: unknown. During the same period patient was treated with FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN. Patient died on 10/08/2007.
GASTROINTESTINAL PERFORATION : Capecitabine Side Effects Report #5500901-7
Physician from UNITED STATES reported CAPECITABINE problem on Oct 25, 2007. Female patient was diagnosed with colon cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient died on 08/25/2007.
GASTROINTESTINAL PERFORATION : Temodal Side Effects Report #5445945-9
TEMODAL problem was reported by a Physician from JAPAN on Aug 30, 2007. Male patient, 67 years of age, weighting 110.2 lb, was diagnosed with anaplastic astrocytoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, neutrophil count decreased, septic shock, white blood cell count increased, . TEMODAL dosage: 120 MG/M2; QD; PO, 120 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, GLYCEOL, DECADRON, NAUZELIN, MAGMITT, FAMOTIDINE. Patient was hospitalized. Patient died.
GASTROINTESTINAL PERFORATION : Bevacizumab Side Effects Report #5453904-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Sept 05, 2007. Female patient was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, hypokalaemia, hypomagnesaemia, hyponatraemia, septic shock, . BEVACIZUMAB dosage: 803 MG/KG, UNK. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOPHEN, SIMETHICONE, AMBIEN, AMLODIPINE, APREPITANT. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Fosamax Side Effects Report #5467620-7
FOSAMAX problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2007. Female patient was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, ulcer, . FOSAMAX dosage: unknown. Patient recovered.
GASTROINTESTINAL PERFORATION : Rituxan Side Effects Report #5406408-X
Consumer or non-health professional from GERMANY reported RITUXAN problem on July 30, 2007. Male patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . RITUXAN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SEVREDOL, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Rituxan Side Effects Report #5407073-8
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 30, 2007. Male patient, weighting 178.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, myocardial infarction, . RITUXAN dosage: unknown. During the same period patient was treated with PREDNISOLONE, SEVREDOL, FENTANYL. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Capecitabine Side Effects Report #5420909-X
Physician from UNITED STATES reported CAPECITABINE problem on Aug 10, 2007. Female patient, 66 years of age, was diagnosed with colon cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient recovered.
GASTROINTESTINAL PERFORATION : Gemcitabine Side Effects Report #5422553-7
GEMCITABINE problem was reported by a Physician from JAPAN on Aug 16, 2007. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, malignant ascites, malignant neoplasm progression, subileus, . GEMCITABINE dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died on 02/16/2007.
GASTROINTESTINAL PERFORATION : Lortab Side Effects Report #5391414-4
Physician from UNITED STATES reported LORTAB problem on July 18, 2007. Male patient was diagnosed with colorectal cancer and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . LORTAB dosage: unknown. During the same period patient was treated with FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Mabthera Side Effects Report #5396793-X
MABTHERA problem was reported by a Physician from GERMANY on July 17, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . MABTHERA dosage: unknown. Patient recovered.
GASTROINTESTINAL PERFORATION : Mabthera Side Effects Report #5396905-8
Physician from UNITED KINGDOM reported MABTHERA problem on July 17, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, myocardial infarction, . MABTHERA dosage: unknown. Patient recovered.
GASTROINTESTINAL PERFORATION : Lortab Side Effects Report #5391414-4
LORTAB problem was reported by a Physician from UNITED STATES on July 18, 2007. Male patient was diagnosed with colorectal cancer and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . LORTAB dosage: unknown. During the same period patient was treated with FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Mabthera Side Effects Report #5396793-X
Physician from GERMANY reported MABTHERA problem on July 17, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, . MABTHERA dosage: unknown. Patient recovered.
GASTROINTESTINAL PERFORATION : Mabthera Side Effects Report #5396905-8
MABTHERA problem was reported by a Physician from UNITED KINGDOM on July 17, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, myocardial infarction, . MABTHERA dosage: unknown. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5661452-2
Physician from UNITED KINGDOM reported AVASTIN problem on Feb 27, 2008. Male patient, weighting 132.3 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal perforation, neoplasm progression, oedema, . AVASTIN dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Esomeprazole Side Effects Report #5669787-4
ESOMEPRAZOLE MAGNESIUM problem was reported by a Physician from JAPAN on Mar 04, 2008. Female patient, 68 years of age, weighting 116.8 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoarthritis, eczema, lumbar spinal stenosis, hyperlipidaemia, cataract and was treated with ESOMEPRAZOLE MAGNESIUM. After drug was administered, patient experienced the following problems/side effects: arteritis, gastrointestinal perforation, liver disorder, necrosis, paraesthesia, pyelonephritis, . ESOMEPRAZOLE MAGNESIUM dosage: unknown. During the same period patient was treated with MOBIC, MYSER, OPALMON, LIPITOR, ARTZ DISPO, XYLOCAINE, MUCOSTA, KARY UNI. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Enbrel Side Effects Report #5676188-1
Physician from JAPAN reported ENBREL problem on Mar 10, 2008. Male patient, weighting 158.7 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: dermatitis psoriasiform, gastrointestinal perforation, peritonitis, . ENBREL dosage: unknown. During the same period patient was treated with OPALMON, AZULFIDINE EN, BUCILLAMINE, FOLIAMIN, PREDNISONE, SELBEX, ISCOTIN. Patient was hospitalized. Patient died on 12/08/2007.
GASTROINTESTINAL PERFORATION : Enbrel Side Effects Report #5630499-4
ENBREL problem was reported by a Physician from FRANCE on Feb 07, 2008. Male patient was diagnosed with ankylosing spondylitis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: crohn's disease, gastrointestinal perforation, intestinal obstruction, peritonitis, pneumonia aspiration, post procedural sepsis, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Xeloda Side Effects Report #5643273-X
Physician from ISRAEL reported XELODA problem on Feb 17, 2008. Male patient, 75 years of age, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal perforation, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, pancytopenia, . XELODA dosage: unknown. Patient was hospitalized. Patient died.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5582210-3
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Dec 21, 2007. Female patient, weighting 105.8 lb, was diagnosed with neuroendocrine carcinoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: anuria, gastrointestinal perforation, neoplasm progression, . AVASTIN dosage: 2.5 MG/KG, SINGLE. During the same period patient was treated with TAXOL. Patient died on 11/01/2007.
GASTROINTESTINAL PERFORATION : Xeloda Side Effects Report #5591620-X
Physician from CANADA reported XELODA problem on Jan 08, 2008. Female patient was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cough, gastrointestinal perforation, pyrexia, . XELODA dosage: unknown. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5598519-3
AVASTIN problem was reported by a Physician from CANADA on Jan 08, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: cough, gastrointestinal perforation, pyrexia, . AVASTIN dosage: unknown. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Fosamax Side Effects Report #5550987-9
Consumer or non-health professional from UNITED STATES reported FOSAMAX problem on Dec 07, 2007. Male patient, 50 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: diverticulitis, gastrointestinal perforation, . FOSAMAX dosage: unknown. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Fosamax Side Effects Report #5564204-7
FOSAMAX problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Male patient, 50 years of age, was diagnosed with osteoporosis, diverticulitis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: diverticulitis, gastrointestinal perforation, liver abscess, . FOSAMAX dosage: unknown. During the same period patient was treated with PREVACID, DONNATAL, PRILOSEC. Patient was hospitalized. Patient recovered.
GASTROINTESTINAL PERFORATION : Pemetrexed Side Effects Report #5567021-7
Physician from JAPAN reported PEMETREXED problem on Dec 13, 2007. Male patient, weighting 103.6 lb, was diagnosed with pleural mesothelioma, vitamin supplementation, cancer pain and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, gastrointestinal perforation, stress cardiomyopathy, . PEMETREXED dosage: 740 MG, OTHER. During the same period patient was treated with CISPLATIN, PANVITAN, CYANOCOBALAMIN, GOODMIN, POSTERISANTE, OXYCONTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/31/2007.
GASTROINTESTINAL PERFORATION : Indocin Side Effects Report #5573951-2
INDOCIN I problem was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient was diagnosed with patent ductus arteriosus and was treated with INDOCIN I. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal perforation, hypotension, intraventricular haemorrhage, metabolic acidosis, . INDOCIN I dosage: 0.1 MG/KG; BID; IV, 0.2 MG/KG; BID; IV. During the same period patient was treated with INDOCIN I, SURFACTANT. Patient died on 11/17/2007.
GASTROINTESTINAL PERFORATION : Indocin Side Effects Report #5573954-8
Physician from UNITED STATES reported INDOCIN I problem on Dec 06, 2007. Male patient was diagnosed with patent ductus arteriosus, prophylaxis and was treated with INDOCIN I. After drug was administered, patient experienced the following problems/side effects: acute abdomen, gastrointestinal perforation, . INDOCIN I dosage: unknown. During the same period patient was treated with INDOCIN I, INDOCIN I, INDOCIN I, SURFACTANT. Patient died.
GASTROINTESTINAL PERFORATION : Kaletra Side Effects Report #5576767-6
KALETRA problem was reported by a Physician from JAPAN on Dec 19, 2007. Male patient was diagnosed with hiv infection, cytomegalovirus test, antibiotic prophylaxis, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: colon operation, gastrointestinal perforation, hyperamylasaemia, hyperlipidaemia, liver disorder, white blood cell count decreased, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, GANCICLOVIR, AZITHROMYCIN, BACTRIM. Patient was hospitalized and became disabled. Patient recovered.
GASTROINTESTINAL PERFORATION : Bevacizumab Side Effects Report #5514761-1
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Oct 29, 2007. Female patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, gastrointestinal perforation, intestinal obstruction, wound dehiscence, . BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, KYTRIL, DECADRON, AMOBAN. Patient died on 10/03/2007.
GASTROINTESTINAL PERFORATION : Kaletra Side Effects Report #5490982-1
KALETRA problem was reported by a Physician from JAPAN on Oct 11, 2007. Male patient was diagnosed with hiv infection, cytomegalovirus test, antibiotic prophylaxis, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: colon operation, gastrointestinal perforation, hyperamylasaemia, hyperlipidaemia, liver disorder, white blood cell count decreased, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, GANCICLOVIR, AZITHROMYCIN, BACTRIM. Patient was hospitalized and became disabled. Patient recovered.
GASTROINTESTINAL PERFORATION : Avastin Side Effects Report #5494768-3
Physician from UNITED KINGDOM reported AVASTIN problem on Oct 10, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal perforation, intestinal ischaemia, nausea, . AVASTIN dosage: 825 MG, UNK. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.